The Diagnostic Utility of a Myeloid Mutational Panel for Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms

Authors

Warda Ibrar, University of Nebraska Medical CenterFollow
Jesse Cox, University of Nebraska Medical CenterFollow
Catalina Amador, University of Nebraska Medical CenterFollow
Hina N. Qureishi, University of Nebraska Medical CenterFollow
Kai Fu, University of Nebraska Medical Center
Timothy C. Greiner, University of Nebraska Medical CenterFollow
Allison Vokoun, University of Nebraska Medical CenterFollow
Weiwei Zhang, University of Nebraska Medical CenterFollow
Yuan Ji, University of Nebraska Medical Center

Document Type

Conference Proceeding

Disciplines

Higher Education | Medicine and Health Sciences

DOI

10.32873/unmc.dc.gmerj.2.1.055

Creative Commons License

This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 4.0 License.

Recommended Citation

Ibrar, W., Cox, J., Amador, C., Qureishi, H. N., Fu, K., Greiner, T. C., Vokoun, A., Zhang, W., , Ji, Y. The Diagnostic Utility of a Myeloid Mutational Panel for Myelodysplastic Syndromes and Myelodysplastic/Myeloproliferative Neoplasms. Graduate Medical Education Research Journal. 2020 Sep 29; 2(1).
https://digitalcommons.unmc.edu/gmerj/vol2/iss1/57